Short answer
Abbott Laboratories (ABT) filed an 8-K current report with the SEC on April 16, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Signature page dated April 16, 2026, executed by Abbott’s Executive Vice President, Finance and CFO.
Abbott Laboratories 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Signature page dated April 16, 2026, executed by Abbott’s Executive Vice President, Finance and CFO
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Abbott Laboratories 8-K filings
Get the next ABT 8-K as it lands
Follow ABT for push alerts, or ask the research agent what this filing means.